Status:

COMPLETED

SAFE Workplace Intervention for People with IDD

Lead Sponsor:

Temple University

Collaborating Sponsors:

National Institute on Disability, Independent Living, and Rehabilitation Research

Conditions:

Communicable Diseases

Prevention

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of this study is to examine the feasibility and efficacy of a systematic training approach targeting behaviors to increase safety and prevention of airborne diseases such as COVID-19 in th...

Detailed Description

It is hypothesized that the SAFE program will have a positive effect on perceived well-being and knowledge of the actionable behaviors for the prevention of COVID-19 and other airborne diseases. The p...

Eligibility Criteria

Inclusion

  • The researchers anticipate recruiting young adults 18years old and over with ASD or IDD who are currently employed or actively looking for employment to participate in the study. Participants will have a diagnosis of ASD or IDD. Participants will self-report their ASD or IDD diagnosis. Additionally, the community agencies have access to documentation that identifies their consumer's diagnoses. Based on this, the researchers will ask them to only provide information to those individuals who have a diagnosis of IDD. Potentially eligible participants with documented intellectual and developmental disabilities will be recruited through large vocational rehabilitation organizations (Community Integrated Services CIS and Project Search) that together serve over 1200 adults with IDD. Participants must be working a minimum of 10 hours a week outside the home and/or receive vocational rehabilitation services.

Exclusion

  • under 18 years, do not have a minimum of 10 hours/week of work experience, do not have Autism Spectrum Disorder and/or Intellectual Disability

Key Trial Info

Start Date :

September 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2024

Estimated Enrollment :

65 Patients enrolled

Trial Details

Trial ID

NCT06112249

Start Date

September 1 2021

End Date

September 1 2024

Last Update

December 6 2024

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

JEVS

Collingswood, New Jersey, United States, 08108

2

Community Integrated Services

Philadelphia, Pennsylvania, United States, 19123